J. Wanders

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Javier Cortés, Joyce O’Shaughnessy, David Loesch et al. · The Lancet · 2011 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +9

New guidelines to evaluate the response to treatment in solid tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · Breast Cancer · 2005 · 662 citations

Medicine, Oncology, Cancer Pharmacology +12

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

Andrea Ardizzoni, H. Hansen, P Dombernowsky et al. · Journal of Clinical Oncology · 1997 · 481 citations

Medicine, Oncology, Pharmacology +14

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin

M. Borner, Patrick Schöffski, Ronald de Wit et al. · European Journal of Cancer · 2002 · 319 citations

Pharmacy, Pharmacokinetics, Pharmacology +11